TRCT
ICCC icon

Tower Research Capital (TRC)’s ImmuCell ICCC Stock Holding History

Tower Research Capital (TRC)’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,017
Closed -$4.87K – 5398
2025
Q1 		$4.87K Buy
1,017
+211
+26% +$1.08K ﹤0.01% 4188
2024
Q4 		$4.15K Sell
806
-310
-28% -$1.24K ﹤0.01% 4507
2024
Q3 		$4.05K Sell
1,116
-651
-37% -$2.53K ﹤0.01% 4698
2024
Q2 		$8.57K Sell
1,767
-236
-12% -$1.14K ﹤0.01% 4335
2024
Q1 		$10.6K Sell
2,003
-61
-3% -$314 ﹤0.01% 3674
2023
Q4 		$10.5K Buy
2,064
+429
+26% +$2.09K ﹤0.01% 4237
2023
Q3 		$8.73K Sell
1,635
-2,767
-63% -$14K ﹤0.01% 4311
2023
Q2 		$22K Buy
4,402
+2,067
+89% +$10.6K ﹤0.01% 3304
2023
Q1 		$12K Buy
2,335
+1,059
+83% +$6.88K ﹤0.01% 4086
2022
Q4 		$8K Buy
+1,276
New +$9.21K ﹤0.01% 4407
2022
Q3 		– Sell
-153
Closed -$1K – 6252
2022
Q2 		$1K Buy
+153
New +$1.33K ﹤0.01% 5803
2022
Q1 		– Sell
-100
Closed -$1K – 6287
2021
Q4 		$1K Buy
+100
New +$893 ﹤0.01% 5830
2021
Q3 		– Sell
-426
Closed -$4K – 5931
2021
Q2 		$4K Sell
426
-320
-43% -$3.12K ﹤0.01% 4820
2021
Q1 		$7K Buy
746
+564
+310% +$5.29K ﹤0.01% 4529
2020
Q4 		$1K Sell
182
-125
-41% -$728 ﹤0.01% 5004
2020
Q3 		$2K Buy
+307
New +$1.7K ﹤0.01% 4595
2020
Q1 		– Sell
-1,773
Closed -$9K – 3431
2019
Q4 		$9K Buy
1,773
+936
+112% +$4.83K ﹤0.01% 2384
2019
Q3 		$5K Buy
837
+777
+1,295% +$4.54K ﹤0.01% 3305
2019
Q2 		$0 Sell
60
-655
-92% -$4.16K ﹤0.01% 3946
2019
Q1 		$5K Buy
715
+173
+32% +$1.24K ﹤0.01% 3058
2018
Q4 		$4K Buy
542
+247
+84% +$1.91K ﹤0.01% 3036
2018
Q3 		$2K Buy
295
+127
+76% +$914 ﹤0.01% 3433
2018
Q2 		$1K Buy
+168
New +$1.21K ﹤0.01% 3482
2018
Q1 		– Sell
-53
Closed – – 3520
2017
Q4 		$0 Buy
+53
New +$434 ﹤0.01% 3734
2017
Q3 		– Sell
-59
Closed – – 3944
2017
Q2 		$0 Sell
59
-478
-89% -$2.84K ﹤0.01% 3033
2017
Q1 		$3K Buy
+537
New +$3.08K ﹤0.01% 2471
2016
Q4 		– Sell
-551
Closed -$4K – 4080
2016
Q3 		$4K Buy
551
+221
+67% +$1.61K ﹤0.01% 2677
2016
Q2 		$2K Sell
330
-370
-53% -$2.5K ﹤0.01% 3903
2016
Q1 		$5K Buy
+700
New +$4.67K ﹤0.01% 2688
2015
Q4 		– Sell
-799
Closed -$5K – 4721
2015
Q3 		$5K Sell
799
-32
-4% -$261 ﹤0.01% 2799
2015
Q2 		$7K Buy
831
+134
+19% +$920 ﹤0.01% 2995
2015
Q1 		$4K Sell
697
-133
-16% -$839 ﹤0.01% 3400
2014
Q4 		$4K Buy
830
+726
+698% +$3.46K ﹤0.01% 2871
2014
Q3 		$1K Sell
104
-154
-60% -$720 ﹤0.01% 4095
2014
Q2 		$1K Buy
258
+251
+3,586% +$1.06K ﹤0.01% 3679
2014
Q1 		$0 Sell
7
-776
-99% -$3.38K ﹤0.01% 4652
2013
Q4 		$3K Buy
+783
New +$3.39K ﹤0.01% 3843
2013
Q3 		– Sell
-254
Closed -$1K – 4666
2013
Q2 		$1K Buy
+254
New +$910 ﹤0.01% 3686

Other funds holding ICCC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

Tower Research Capital (TRC)'s ICCC Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of ImmuCell (ICCC) in Q2 2025, closing a stake of 1,017 shares — an estimated $4.87K sold.

Tower Research Capital (TRC) first reported a position in ICCC in Q2 2013 and held it in 38 quarters. The position peaked at $22K in Q2 2023. 25 funds tracked by Wall St. Rank hold ICCC as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining ImmuCell position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,017 ImmuCell shares in Q2 2025, an estimated $4.87K.
  • Tower Research Capital (TRC) first reported a position in ImmuCell in Q2 2013 and held it in 38 quarters.
  • Tower Research Capital (TRC)'s ImmuCell position peaked at $22K in Q2 2023.
  • 25 funds tracked by Wall St. Rank held ImmuCell as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.